Catalyst Wire Dossier Catalyst Wire Dossier

XAF5 (XOPH5) Ointment

· Topokine Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XAF5 (XOPH5) Ointment, covering 2016-02-08 to 2016-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon) [Phase 2]

See pricing